Literature DB >> 15983339

Non-HDL cholesterol is less informative than the total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetes.

Rury R Holman1, Ruth L Coleman, Brian S F Shine, Richard J Stevens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15983339     DOI： 10.2337/diacare.28.7.1796

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  18 in total

1.  Additive effects of glycaemia and dyslipidaemia on risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register.

Authors:  S Gudbjörnsdottir; B Eliasson; K Eeg-Olofsson; B Zethelius; J Cederholm
Journal:  Diabetologia       Date:  2011-06-15       Impact factor: 10.122

Review 2.  Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes.

Authors:  N John Bosomworth
Journal:  Can Fam Physician       Date:  2013-11       Impact factor: 3.275

3.  Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence.

Authors:  Michel P Hermans; Frank M Sacks; Sylvie A Ahn; Michel F Rousseau
Journal:  Cardiovasc Diabetol       Date:  2011-02-28       Impact factor: 9.951

4.  Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register.

Authors:  Björn Eliasson; Jan Cederholm; Katarina Eeg-Olofsson; Anne-Marie Svensson; Björn Zethelius; Soffia Gudbjörnsdottir
Journal:  Diabetes Care       Date:  2011-07-20       Impact factor: 19.112

5.  Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events.

Authors:  Sanjay K Gandhi; Marie M Jensen; Kathleen M Fox; Lee Smolen; Anders G Olsson; Thomas Paulsson
Journal:  Clinicoecon Outcomes Res       Date:  2012-01-10

6.  Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study.

Authors:  Hirohito Sone; Sachiko Tanaka; Shiro Tanaka; Satoshi Iimuro; Shun Ishibashi; Shinichi Oikawa; Hitoshi Shimano; Shigehiro Katayama; Yasuo Ohashi; Yasuo Akanuma; Nobuhiro Yamada
Journal:  Diabetes Care       Date:  2012-02-14       Impact factor: 19.112

7.  Abatacept improves whole-body insulin sensitivity in rheumatoid arthritis: an observational study.

Authors:  Francesco Ursini; Emilio Russo; Marta Letizia Hribal; Daniele Mauro; Francesca Savarino; Caterina Bruno; Cesare Tripolino; Mariangela Rubino; Saverio Naty; Rosa Daniela Grembiale
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

8.  The combined effect of visit-to-visit variability in HbA1c and systolic blood pressure on the incidence of cardiovascular events in patients with type 2 diabetes.

Authors:  Toshiko Takao; Yutaka Matsuyama; Machi Suka; Hiroyuki Yanagisawa; Yasuhiko Iwamoto
Journal:  BMJ Open Diabetes Res Care       Date:  2015-11-13

9.  Lipid measures for prediction of incident cardiovascular disease in diabetic and non-diabetic adults: results of the 8.6 years follow-up of a population based cohort study.

Authors:  Maryam Tohidi; Masumeh Hatami; Farzad Hadaegh; Maryam Safarkhani; Hadi Harati; Fereidoun Azizi
Journal:  Lipids Health Dis       Date:  2010-01-23       Impact factor: 3.876

10.  Total/high density lipoprotein cholesterol and cardiovascular disease (re)hospitalization nadir in type 2 diabetes.

Authors:  Dahai Yu; Yamei Cai; Rui Qin; Jonathan Graffy; Daniel Holman; Zhanzheng Zhao; David Simmons
Journal:  J Lipid Res       Date:  2018-06-29       Impact factor: 5.922
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.